Europe PACS and RIS Market to 2027 - Regional Analysis and Forecasts by Product (PACS and RIS), Component (Hardware, Software, and Services), Deployment (Web-Based, On-Premise and Cloud-Based), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Other End Users), and Country
- THE3276286
- 148 Pages
- September 2019
- Healthcare
The growth of the PACS and RIS market is primarily attributed to the developments in diagnostic imaging modalities coupled with rising number of diagnostic tests procedures and new product launches & FDA approvals. However, availability of better substitutes is likely to pose a negative impact on the market growth. On the other hand, growing medical technology industry the European region is likely to have a positive impact on the growth of the PACS and RIS market in the coming years.
During recent years, there have been a various developments in imaging modalities within healthcare for diagnostic purposes. Radiology has developed as a recent trend towards computerized management in the health service and has responded to the demand for cost-efficient and rapid communication between departments of radiology and their users. Medical imaging is a vital part in medical care and treatment across the region. Rising awareness regarding early diagnosis of diseases has led to an increase in the total number of diagnostic tests procedures performed around the world. According to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2016 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). As per the World Health Organization (WHO), with improved health care policy and the better availability of medical equipment, there has been rise in the number of global imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the region resulting in increasing requirement of consumables for tests are likely expected to drive the growth of the PACS and RIS market over the coming years in the region.
In 2018, the Picture Archive and Communication System (PACS) segment held the most significant market share in the PACS and RIS market, by product. This segment is also anticipated to dominate the market in 2027 as the solution offers benefits such as improved viewing and analysis, easy access to images and other reports, efficient data management as well as a user-friendly interface. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the software segment held a most significant market share of the PACS and RIS market, by component. This segment is also estimated to dominate the market in 2027 since software form an integral part of PACS and RIS. Software used in PACS and RIS is a central-server solution that offers all clinics and departments assistance during procedures. Also, the segment is also anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the web-based segment held the most significant market share the PACS and RIS market, by deployment. This segment is also projected to dominate the market in 2027 due to benefits such as enhanced service for physicians as well as improved patient care. However, the cloud-based segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027, due to the increased adoption as well as the development of cloud-based solutions.
In 2018, the hospitals segment held a considerable market share of the PACS and RIS market, by end user. This segment is also predicted to dominate the market in 2027 owing to the availability of better healthcare facilities as well as the presence of reimbursement policies that lead to growth in the number of procedures conducted. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
Some of the major primary and secondary sources for PACS and RIS included in the report are, Business Monitor International (BMI), Digital Imaging and Communications in Medicine (DICOM), The Groupement Radiologues Associés (GRA), Health Information Systems (HIS), The Food and Drug Administration (FDA)
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe PACS and RIS Market - Key Takeaways
3. Europe PACS and RIS Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe PACS and RIS Market - By Product
3.2.2 Europe PACS and RIS Market - By Component
3.2.3 Europe PACS and RIS Market - By Deployment
3.2.4 Europe PACS and RIS Market - By End User
3.2.5 Europe PACS and RIS Market - By Country
3.3 PEST Analysis
4. Europe PACS and RIS Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures
4.1.2 New Product Launches & FDA Approvals
4.2 Key Market Restraints
4.2.1 Availability of Better Substitutes
4.3 Key Market Opportunities
4.3.1 Growing Medical Technology Industry The European Region
4.4 Trend
4.4.1 Increase in Dental Workforce
4.5 Impact Analysis
5. PACS and RIS Market - Europe Analysis
5.1 Europe PACS and RIS Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Company Share By Geography (2018)
6. Europe PACS and RIS Market Analysis - By Product
6.1 Overview
6.2 Europe PACS and RIS Market By Product, 2018 & 2027 (%)
6.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Picture Archive and Communication System (PACS) Market
6.4.1 Overview
6.4.2 Europe Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Radiology Information System (RIS) Market
6.5.1 Overview
6.5.2 Europe Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
7. Europe PACS and RIS Market Analysis - By Component
7.1 Overview
7.2 Europe PACS and RIS Market, By Component, 2018 & 2027 (%)
7.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
7.4 Software Market
7.4.1 Overview
7.4.2 Europe Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hardware Market
7.5.1 Overview
7.5.2 Europe Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Services Market
7.6.1 Overview
7.6.2 Europe Services Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe PACS and RIS Market Analysis- by Deployment
8.1 Overview
8.2 Europe PACS and RIS Market, By Deployment 2018 & 2027 (%)
8.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
8.4 Web-Based Market
8.4.1 Overview
8.4.2 Europe Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 On-Premise Market
8.5.1 Overview
8.5.2 Europe On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Cloud-Based Market
8.6.1 Overview
8.6.2 Europe Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe PACS and RIS Market Analysis- by End User
9.1 Overview
9.2 Europe PACS and RIS Market, By End User 2018 & 2027 (%)
9.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Diagnostic Centers Market
9.5.1 Overview
9.5.2 Europe Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others Market
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Europe PACS and RIS Market Revenue and Forecasts To 2027
10.1 Overview
10.2 Europe PACS and RIS Market Revenue And Forecasts to 2027 (US$ Mn)
10.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.5 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.6 Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
10.7.1 UK PACS and RIS Market Revenue and Forecasts To 2027 (US$ Mn)
10.7.1.1 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.1.2 UK PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.1.3 UK PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.1.4 UK PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.1.5 UK PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.2 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2.1 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2.2 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.2.3 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.2.4 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.2.5 Germany PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.3 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3.1 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3.2 France PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3.3 France PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.3.4 France PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.3.5 France PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.4 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.4.1 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.4.2 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.4.3 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.4.4 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.4.5 Italy PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7.5 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.5.1 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.5.2 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.5.3 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
10.7.5.4 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
10.7.5.5 Spain PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. PACS and RIS Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies In The PACS and RIS Market, 2016-2019
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
11.4.1 Collaborations
11.4.1.1 Recent Collaborations By Players In The PACS and RIS Market
11.4.2 Agreements, Partnerships and Joint Ventures
11.4.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
11.4.3 Acquisitions
11.4.3.1 Recent Acquisitions By Players In The PACS and RIS Market
11.5 Organic Growth Strategies
11.5.1 Overview
11.6 Organic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
11.6.1 Product Launches
11.6.1.1 Recent Product Launches By Players In The PACS and RIS Market
11.6.2 Product Approval & Other Organic Growth Strategies
11.6.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market
12. PACS and RIS Market-Key Company Profiles
12.1 Agfa-Gevaert Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 INFINITT Healthcare Co., Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 McKesson Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cerner Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric Company
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 FUJIFILM Holdings Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Siemens AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 IBM
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Novarad
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
Table 1. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 2. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 3. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 4. Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 5. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 7. Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 8. Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. UK PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. UK PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 11. UK PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 12. UK PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Germany PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 14. Germany PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 15. Germany PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 16. Germany PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. France PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. France PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 19. France PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 20. France PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. Italy PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 22. Italy PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 23. Italy PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 24. Italy PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 25. Spain PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 26. Spain PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
Table 27. Spain PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
Table 28. Spain PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 29. Recent Collaborations By Players In The PACS and RIS Market
Table 30. Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
Table 31. Recent Acquisitions By Players In The PACS and RIS Market
Table 32. Recent Product Launches in the PACS and RIS Market
Table 33. Recent Product Approval & Other Organic Growth Strategies in the PACS and RIS Market
Table 34. Glossary Of Terms, PACS and RIS Market
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
